Sun Yu, CEO of Roulun Tech, Speaks at 2025 Boao Lecheng Frontier Biomedical Technology Conference on the Future of Brain-Computer Interfaces

From June 21 to 22, co-organized by the Life Science Society Joint Body of the China Association for Science and Technology and Hainan University2025 Boao Lecheng Cutting-Edge Biomedical Technology ConferenceThe conference was grandly held in Boao, Hainan. The event brought together several academicians and top experts in the global biomedicine field, including Anming Meng, Yuzhang Wu, Guoliang Xu, Jizong Zhao, Lanjuan Li, and Weizhi Ji, for in-depth discussions on cutting-edge technologies such as gene therapy, cell therapy, AI healthcare, and brain-computer interfaces.Founder and CEO of FlectoThinkDr. Sun Yu, CEOInvited to Attend`, to jointly explore the innovative applications and future trends of brain-computer interface technology in the healthcare field with top scholars, medical experts, and industry leaders both in China and abroad.`

At the conference, Dr. Sun Yu delivered a speech titled "Flexible Brain-Computer Interface: Making Future Healthcare More Seamless and Accessible." He provided an in-depth analysis of the current challenges and opportunities in brain-computer interface technology. He pointed out that traditional brain-computer interface devices, limited by rigid materials and invasive techniques, struggle to achieve large-scale clinical application. In contrast, FlectoThink's self-developed nanomaterial electrodes, non-invasive brain-computer interface technology, and artificial intelligence innovations are driving brain-computer interaction toward being "lightweight, comfortable, and suitable for home use."

Dr. Sun Yu emphasized: "Brain-computer interface should not only be a 'black technology' confined to the laboratory, but should become an accessible health management tool for the general public. Breakthroughs in brain-computer interface technology will accelerate its application in scenarios such as sleep disorder treatment and stroke rehabilitation."

During the conference, FlectoThink showcased several representative products, including:EEG Sleep Monitor,Combined with an adaptive noise reduction algorithm, it effectively filters out environmental interference (such as electromagnetic waves and muscle activity), ensuring data reliability. Clinical validation shows that its sleep stage classification accuracy rate is over 92%. Forehead-Paste Type Brain-Computer Sleep Aid Device：Adopting cutting-edge nano-flexible patented electrodes and AI intelligent algorithms, it can track users' sleep architecture in real time, accurately perform sleep staging, and effectively extract sleep characteristic waves.These achievements have attracted widespread attention from experts, investment institutions, and medical companies at the conference. Many international peers have described it as "a crucial step towards the democratization of brain-computer interfaces."

During the roundtable discussion, Dr. Sun Yu reached a consensus with experts in the fields of neuroscience and artificial intelligence: the deep integration of artificial intelligence, AI algorithms, and medical scenarios will completely transform the diagnosis and treatment model of neurological diseases. FlectoThink will continue to focus on the "home-based healthcare" scenario, bringing high-performance brain-computer interface devices into millions of households.